Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Bioequivalence of a Natural Extract Versus the Assumed Key Active Compound in Reducing the Post-prandial Blood Glucose Levels

NCT02599740 is registered in ClinicalTrials.gov with Unilever R&D as lead sponsor.

NCT NCT02599740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02599740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Bioequivalence of a Natural Extract Versus the Assumed Key Active Compound in Reducing the Post-prandial Blood Glucose Levels
Lead sponsor
Unilever R&D
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2015
Completion date
December 31, 2015
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy